Zerit and Iddm - a phase IV clinical study of FDA data
Summary:
Iddm is reported as a side effect among people who take Zerit (stavudine), especially for people who are male, 40-49 old, have been taking the drug for 5 - 10 years also take Crixivan, and have Hiv infection.
The phase IV clinical study analyzes which people have Iddm when taking Zerit. It is created by eHealthMe based on reports of 9,900 people who have side effects when taking Zerit from the FDA, and is updated regularly.
What is Zerit?
Zerit has active ingredients of stavudine. eHealthMe is studying from 9,912 Zerit users. Check the latest studies of Zerit.
What is Iddm?
Iddm is found to be associated with 842 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Iddm.
9,900 people reported to have side effects when taking Zerit.
Among them, 27 people (0.27%) have Iddm.

Among these 27 people:
How long have people been on Zerit when they have Iddm? *
- < 1 month: 0.0 %
- 1 - 6 months: 12.5 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 12.5 %
- 5 - 10 years: 75.0 %
- 10+ years: 0.0 %
What is the gender of people who have Iddm when taking Zerit? *
- female: 11.54 %
- male: 88.46 %
What is the age of people who have Iddm when taking Zerit? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 24 %
- 20-29: 0.0 %
- 30-39: 8 %
- 40-49: 40 %
- 50-59: 24 %
- 60+: 4 %
What are other drugs people take besides Zerit? *
- Crixivan: 13 people, 48.15%
- Lamivudine: 12 people, 44.44%
- Videx: 11 people, 40.74%
- Epivir: 9 people, 33.33%
- Norvir: 8 people, 29.63%
- Invirase: 7 people, 25.93%
- Zidovudine: 7 people, 25.93%
- Diflucan: 6 people, 22.22%
- Efavirenz: 4 people, 14.81%
- Viramune: 3 people, 11.11%
What are other side effects people have besides Iddm? *
- Urination - Excessive Volume: 7 people, 25.93%
- Weight Decreased: 6 people, 22.22%
- Pancreatitis Haemorrhagic (inflammation of pancreas with bleeding): 6 people, 22.22%
- Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 22.22%
- Thirst - Excessive: 5 people, 18.52%
- Fever: 4 people, 14.81%
- Hypertriglyceridaemia (excess of triglycerides in the blood): 4 people, 14.81%
- Blood Glucose Increased: 3 people, 11.11%
- Acute Kidney Failure: 2 people, 7.41%
- Lactic Acidosis (low ph in body tissues): 2 people, 7.41%
What are the existing conditions these people have? *
- Hiv Infection: 11 people, 40.74%
- Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 6 people, 22.22%
- High Blood Cholesterol: 1 person, 3.70%
- Hepatitis C: 1 person, 3.70%
* Approximation only. Some reports may have incomplete information.
Do you take Zerit and have Iddm?
- Check whether Iddm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zerit:
- Zerit (9,912 reports)
Iddm treatments and more:
- Iddm (46,844 reports)
How severe was Iddm and when was it recovered:
Expand to all the drugs that have ingredients of stavudine:
- Iddm and drugs with ingredients of stavudine (49 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zerit:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Iddm:
- Iddm (842 drugs)
Browse all the conditions that are associated with Iddm:
- Iddm (1,644 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on stavudine (the active ingredients of Zerit) and Zerit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Dolutegravir cause Renal Failure Aggravated? - 3 seconds ago
- Could Carbidopa, Levodopa And Entacapone cause Memory Loss? - 3 seconds ago
- Could Nuedexta cause Syncope Aggravated? - 5 seconds ago
- Embolism Venous and Urinary Tract Infection - 6 seconds ago
- Ambien and Loss Of Consciousness for Women aged 20-29 - 9 seconds ago
- Allergies and Cytomegalovirus Infection - 10 seconds ago
- Accupril and Carotid Artery Stenosis for Men aged 60+ - 12 seconds ago
- Breast Cancer and Flatulence - 14 seconds ago
- Drug interactions of Novolog and Travatan - 18 seconds ago
- Could Naprosyn cause Rickets? - 20 seconds ago